Changeflow GovPing Healthcare FDA Acknowledges Letter from 3 Foot World
Routine Notice Added Final

FDA Acknowledges Letter from 3 Foot World

Email

Summary

The FDA has acknowledged receipt of a letter from 3 Foot World regarding a matter associated with docket FDA-2026-V-1589. The agency has provided a link to the acknowledgment letter, which was authored by CDRH.

What changed

The Food and Drug Administration (FDA) has issued a notice acknowledging receipt of a letter from an entity named 3 Foot World. This acknowledgment is associated with docket number FDA-2026-V-1589. The document itself is an acknowledgment letter from the FDA's CDRH (Center for Devices and Radiological Health) to 3 Foot World, indicating that the agency has received their correspondence.

This notice serves as a procedural update, confirming the FDA's receipt of communication. There are no new compliance obligations or deadlines imposed on regulated entities as a result of this acknowledgment. Compliance officers should note this communication for their records related to docket FDA-2026-V-1589, but no immediate action is required.

Source document (simplified)

Content

There are no documents available to view or download

Attachments 1

Acknowledgment Letter from FDA DMB to 3 Foot World

More Information
- Author(s) CDRH
Download

Classification

Agency
FDA
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
FDA-2026-V-1589-0002
Docket
FDA-2026-V-1589

Who this affects

Applies to
Drug manufacturers Medical device makers
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing
Activity scope
Regulatory Submissions
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Compliance frameworks
FDA 21 CFR Part 11
Topics
Medical Devices

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Free. Unsubscribe anytime.